Validation of α-synuclein in L1CAM-immunocaptured exosomes as a biomarker for the stratification of Parkinsonian syndromes
<p><strong>Background:</strong> Parkinson’s disease is characterised by intraneuronal α-synuclein aggregation. Currently there is no α-synuclein-based blood test in clinical practice.</p> <p><strong>Objectives:</strong> Our aim was to assess by means of fur...
Main Authors: | Jiang, C, Hopfner, F, Berg, D, Hu, M, Pilotto, A, Borroni, B, Davis, JJ, Tofaris, G |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Wiley
2021
|
Similar Items
-
Alternating magnetic field-promoted nanoparticle mixing: the on-chip immunocapture of serum neuronal exosomes for Parkinson’s disease diagnostics
by: Sharafeldin, M, et al.
Published: (2023) -
Methodological considerations in neuronal extracellular vesicle isolation for α-synuclein biomarkers
by: Yan, S, et al.
Published: (2023) -
Uric acid regulates α-synuclein transmission in Parkinsonian models
by: Yu Jin Shin, et al.
Published: (2023-08-01) -
A critical assessment of exosomes in the pathogenesis and stratification of Parkinson's disease
by: Tofaris, G
Published: (2017) -
Initiation and progression of α-synuclein pathology in Parkinson’s disease
by: Tofaris, GK
Published: (2022)